Two-Level nerve block may offer better pain control after breast cancer surgery
NCT ID NCT05361837
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study compares two types of nerve blocks for pain relief in women undergoing breast cancer surgery. One group receives a single-level block, while another receives a two-level block, with some patients also getting the medication dexmedetomidine. The goal is to see which approach reduces pain and the need for additional painkillers like morphine. The trial involves 172 participants and will also monitor side effects such as nausea and heart rate changes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dexmedetomidine
What this could lead to
If successful, this could lead to a more effective way to manage pain after breast cancer surgery, reducing the need for strong painkillers like morphine.
What could go wrong
This is a single-center study with a moderate number of participants. The results may not apply to all patients, and there is a risk of side effects like nausea, vomiting, or injection-site hematoma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Walaa Y Elsabeeny
RECRUITINGCairo, Cairo Governorate, 11796, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••